205 related articles for article (PubMed ID: 35217937)
1. Polidocanol foam sclerotherapy in the treatment of hemorrhoidal disease in patients with bleeding disorders: a multicenter, prospective, cohort study.
Salgueiro P; Rei A; Garrido M; Rosa B; Oliveira AM; Pereira-Guedes T; Morais S; Castro-Poças F
Tech Coloproctol; 2022 Aug; 26(8):615-625. PubMed ID: 35217937
[TBL] [Abstract][Full Text] [Related]
2. Sclerotherapy with 3% polidocanol foam to treat second-degree haemorrhoidal disease: Three-year follow-up of a multicentre, single arm, IDEAL phase 2b trial.
Gallo G; Picciariello A; Pietroletti R; Novelli E; Sturiale A; Tutino R; Laforgia R; Moggia E; Pozzo M; Roveroni M; Bianco V; Realis Luc A; Giuliani A; Diaco E; Naldini G; Trompetto M; Perinotti R; D'Andrea V; Lobascio P
Colorectal Dis; 2023 Mar; 25(3):386-395. PubMed ID: 36268758
[TBL] [Abstract][Full Text] [Related]
3. Sclerotherapy using 2 % polidocanol foam in the treatment of hemorrhoidal disease - a single-center experience.
Figueiredo LM; Bordalo Ferreira F; Rafael MA; Oliveira AM
Rev Esp Enferm Dig; 2022 Mar; 114(3):185-186. PubMed ID: 34517712
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of sclerotherapy with polidocanol foam in comparison with fluid sclerosant in the treatment of first-grade haemorrhoidal disease: a randomised, controlled, single-blind, multicentre trial.
Moser KH; Mosch C; Walgenbach M; Bussen DG; Kirsch J; Joos AK; Gliem P; Sauerland S
Int J Colorectal Dis; 2013 Oct; 28(10):1439-47. PubMed ID: 23775099
[TBL] [Abstract][Full Text] [Related]
5. Short-Term Results of Sclerotherapy with 3% Polidocanol Foam for Symptomatic Second- and Third-Degree Hemorrhoidal Disease.
Lobascio P; Laforgia R; Novelli E; Perrone F; Di Salvo M; Pezzolla A; Trompetto M; Gallo G
J Invest Surg; 2021 Oct; 34(10):1059-1065. PubMed ID: 32290709
[TBL] [Abstract][Full Text] [Related]
6. A multicentre, open-label, single-arm phase II trial of the efficacy and safety of sclerotherapy using 3% polidocanol foam to treat second-degree haemorrhoids (SCLEROFOAM).
Gallo G; Pietroletti R; Novelli E; Sturiale A; Tutino R; Lobascio P; Laforgia R; Moggia E; Pozzo M; Roveroni M; Bianco V; Luc AR; Giuliani A; Diaco E; Naldini G; Trompetto M; Perinotti R; Sammarco G
Tech Coloproctol; 2022 Aug; 26(8):627-636. PubMed ID: 35334004
[TBL] [Abstract][Full Text] [Related]
7. Polidocanol versus phenol in oil injection sclerotherapy in treatment of internal hemorrhoids: A randomized controlled trial.
Mishra S; Sahoo AK; Elamurugan TP; Jagdish S
Turk J Gastroenterol; 2020 May; 31(5):378-383. PubMed ID: 32519957
[TBL] [Abstract][Full Text] [Related]
8. Treatment of bleeding esophageal varices with cyanoacrylate and polidocanol, or polidocanol alone: results of a prospective study in an unselected group of patients with cirrhosis of the liver.
Lux G; Retterspitz M; Stabenow-Lohbauer U; Langer M; Altendorf-Hofmann A; Bozkurt T
Endoscopy; 1997 May; 29(4):241-6. PubMed ID: 9255525
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
Rabe E; Otto J; Schliephake D; Pannier F
Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of sclerotherapy with polidocanol in children with internal hemorrhoids.
Watanabe T; Ohno M; Tahara K; Tomonaga K; Ogawa K; Takezoe T; Fuchimoto Y; Fujino A; Kanamori Y
Pediatr Int; 2021 Jul; 63(7):813-817. PubMed ID: 33045763
[TBL] [Abstract][Full Text] [Related]
11. 3% polidocanol foam sclerotherapy versus hemorrhoidal artery ligation with recto anal repair in hemorrhoidal disease grades II-III: a randomized, pilot trial.
Neves S; Falcão D; Povo A; Castro-Poças F; Oliveira J; Salgueiro P
Rev Esp Enferm Dig; 2023 Mar; 115(3):115-120. PubMed ID: 35638762
[TBL] [Abstract][Full Text] [Related]
12. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
Uncu H
Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
[TBL] [Abstract][Full Text] [Related]
13. Sclerotherapy for hemorrhoidal disease: systematic review and meta-analysis.
Gallo G; Picciariello A; Armellin C; Lori E; Tomasicchio G; Di Tanna GL; Santoro GA; Alharbi M; Sorrenti S; Grossi U
Tech Coloproctol; 2024 Jan; 28(1):28. PubMed ID: 38261136
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomized comparison of sodium tetradecyl sulfate and polidocanol as variceal sclerosing agents.
Bhargava DK; Singh B; Dogra R; Dasarathy S; Sharma MP
Am J Gastroenterol; 1992 Feb; 87(2):182-6. PubMed ID: 1734694
[TBL] [Abstract][Full Text] [Related]
15. Treatment of male varicoceles by transcatheter polidocanol foam sclerotherapy: evaluation of clinical success, complications, and patients' satisfaction with regard to alternative techniques.
Ali A; Wirth S; Treitl KM; Treitl M
Eur Radiol; 2015 Oct; 25(10):2889-97. PubMed ID: 25796582
[TBL] [Abstract][Full Text] [Related]
16. N-butyl-2-cyanoacrylate (Histoacryl) plus sclerotherapy versus sclerotherapy alone in the treatment of bleeding esophageal varices: a randomized prospective study.
Feretis C; Dimopoulos C; Benakis P; Kalliakmanis B; Apostolidis N
Endoscopy; 1995 Jun; 27(5):355-7. PubMed ID: 7588348
[TBL] [Abstract][Full Text] [Related]
17. [Sclerotherapy of idiopatic hydrocele with polidocanol: a study about 190 cases].
Sallami S; Binous MY; Ben Rhouma S; Chelif M; Hmidi M; Nouira Y; Ben Rais N; Horchani A
Tunis Med; 2011 May; 89(5):440-4. PubMed ID: 21557180
[TBL] [Abstract][Full Text] [Related]
18. Sclerotherapy of internal hemorrhoids using newly devised transparent disposable anorectoscope.
Inoue H; Takemura K; Hori H; Itoh K; Muraoka Y; Yoneshima H; Endo M
Surg Endosc; 1992; 6(3):125-7. PubMed ID: 1502679
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomized comparison of sodium tetradecyl sulphate & polidocanol for oesophageal variceal sclerotherapy.
Ravi M; Kate V; Ananthakrishnan N
Indian J Med Res; 2001 Jun; 113():228-33. PubMed ID: 11816957
[TBL] [Abstract][Full Text] [Related]
20. Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO).
Choi SY; Won JY; Kim KA; Lee DY; Lee KH
Eur Radiol; 2011 Jan; 21(1):122-9. PubMed ID: 20737152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
